Search

everythinglearnresearchcommunity

for

Search:↓

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

EGFR inhibitors can cause yellowish skin eruptions.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

Too much epidermal growth factor can cause hair loss.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

6-Gingerol from ginger may slow down hair growth by affecting certain enzymes and growth factors.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

SOX4 is crucial for the development of melanoma.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

The study created a new method to test drugs that affect hormone processing in skin.

UV photography can help identify people at higher risk for skin cancer, and male pattern baldness at age 45 is linked to a higher risk of certain skin cancers.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Hair follicle development is controlled by interactions between skin tissues and specific molecular signals.

Epidermal stem cells are diverse and vary in activity, playing key roles in skin maintenance and repair.

Stem cell niches support, regulate, and coordinate stem cell functions.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.